UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study

Bone marrow transplantation (Basingstoke), 2019-10, Vol.54 (10), p.1632-1642

2019

Volltextzugriff (PDF)

Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study

Journal of comparative effectiveness research, 2024-04, Vol.13 (4), p.e230131-e230131

2024

Volltextzugriff (PDF)

Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States

Transplant infectious disease, 2020-08, Vol.22 (4), p.e13283-n/a

2020

Volltextzugriff (PDF)

Reference group choice and antibiotic resistance outcomes

Emerging infectious diseases, 2004-06, Vol.10 (6), p.1125-1128

2004

Volltextzugriff (PDF)

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e450-e458

2022

Volltextzugriff (PDF)

Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice

Clinical infectious diseases, 2023-12, Vol.77 (12), p.1626-1634

2023

Volltextzugriff (PDF)

Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19

Clinical infectious diseases, 2024-09

2024

Volltextzugriff (PDF)

Hospitalizations and Mortality Associated with dsDNA Viral Infections Among Hematopoietic Cell Transplant Recipients

Blood, 2015-12, Vol.126 (23), p.2073-2073

2015

Volltextzugriff (PDF)

FRI009 - Non-invasive tests for assessing fibrosis in patients with non-alcoholic fatty liver disease: an evaluation of combining test results

Journal of hepatology, 2020-08, Vol.73, p.S404-S404

2020

Volltextzugriff (PDF)

Non-invasive tests for assessing fibrosis in patients with non-alcoholic fatty liver disease: an evaluation of combining test results

Journal of hepatology, 2020-08, Vol.73, p.S404

2020

Volltextzugriff (PDF)

Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients

Clinical therapeutics, 2024-09

2024

Volltextzugriff (PDF)

Double-Stranded DNA (dsDNA) Viral Infections Among Allogeneic Hematopoietic Cell Transplant (HCT) Recipients in the First Year after Transplant

Blood, 2015-12, Vol.126 (23), p.3296-3296

2015

Volltextzugriff (PDF)

Health and economic outcomes of vancomycin-resistant enterococci

Archives of internal medicine (1960), 2002-10, Vol.162 (19), p.2223

2002

Volltextzugriff (PDF)

Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study

European journal of haematology, 2019-03, Vol.102 (3), p.210-217

2019

Volltextzugriff (PDF)

459. COVID-19 Hospitalization and 30-Day Readmission: A Cohort Study of U.S. Hospitals

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S332-S332

2021

Volltextzugriff (PDF)

Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants

Open forum infectious diseases, 2023-10, Vol.10 (10), p.ofad482-ofad482

2023

Volltextzugriff (PDF)

Comparative effectiveness research in COVID-19 using real-world data: methodological considerations

Journal of comparative effectiveness research, 2021-12, Vol.10 (17), p.1259-1264

2021

Volltextzugriff (PDF)

Remdesivir is associated with reduced mortality in patients hospitalized for COVID-19 not requiring supplemental oxygen

Open forum infectious diseases, 2024-06, Vol.11 (6), p.ofae202

2024

Volltextzugriff (PDF)

1155. Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

Racial and Ethnic Disparities in COVID-19 Treatments in the United States

Journal of racial and ethnic health disparities, 2024-02

2024

Volltextzugriff (PDF)

38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S27-S28

2021

Volltextzugriff (PDF)

Prevalence of Double-Stranded DNA Viral Infections Among Allogeneic Hematopoietic Stem Cell Transplant Recipients

Open forum infectious diseases, 2015-12, Vol.2 (suppl_1)

2015

Volltextzugriff (PDF)

The Direct and Indirect Cost Burden of AcuteCoronary Syndrome

Journal of occupational and environmental medicine, 2011-01, Vol.53 (1), p.2-7

2011

Volltextzugriff (PDF)

Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

Infectious diseases now (Online), 2023-10, Vol.53 (7), p.104760-104760, Article 104760

2023

Volltextzugriff (PDF)

1732. Adenovirus Load Dynamics Are Consistently Correlated With Risk of Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients: Findings From the Landmark AdVance Study

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S58-S59

2018

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(21)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Adult
(10)
Female
(10)
Infectious Diseases
(10)
Male
(10)
Covid-19
(9)
Retrospective Studies
(9)
Immunology
(8)
Middle Aged
(8)
Pharmacology. Drug Treatments
(8)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(7)
Hospitalization
(7)
Mortality
(7)
Pharmacology & Pharmacy
(7)
Health Care Sciences & Services
(6)
Hematology, Oncology And Palliative Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study

Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study

Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States

Reference group choice and antibiotic resistance outcomes

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort

Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice

Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19

Hospitalizations and Mortality Associated with dsDNA Viral Infections Among Hematopoietic Cell Transplant Recipients

FRI009 - Non-invasive tests for assessing fibrosis in patients with non-alcoholic fatty liver disease: an evaluation of combining test results

Non-invasive tests for assessing fibrosis in patients with non-alcoholic fatty liver disease: an evaluation of combining test results

Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients

Double-Stranded DNA (dsDNA) Viral Infections Among Allogeneic Hematopoietic Cell Transplant (HCT) Recipients in the First Year after Transplant

Health and economic outcomes of vancomycin-resistant enterococci

Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study

459. COVID-19 Hospitalization and 30-Day Readmission: A Cohort Study of U.S. Hospitals

Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants

Comparative effectiveness research in COVID-19 using real-world data: methodological considerations

Remdesivir is associated with reduced mortality in patients hospitalized for COVID-19 not requiring supplemental oxygen

1155. Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19

Racial and Ethnic Disparities in COVID-19 Treatments in the United States

38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality

Prevalence of Double-Stranded DNA Viral Infections Among Allogeneic Hematopoietic Stem Cell Transplant Recipients

The Direct and Indirect Cost Burden of AcuteCoronary Syndrome

Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

1732. Adenovirus Load Dynamics Are Consistently Correlated With Risk of Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients: Findings From the Landmark AdVance Study

Aktive Filter

Suchergebnisse filtern